Format

Send to

Choose Destination
Drug Alcohol Depend. 2012 Nov 1;126(1-2):124-30. doi: 10.1016/j.drugalcdep.2012.05.002. Epub 2012 May 26.

12-Step participation reduces medical use costs among adolescents with a history of alcohol and other drug treatment.

Author information

1
Department of Family Medicine, University of Wisconsin School of Medicine and Public Health, Madison 53715, USA. marlon.mundt@fammed.wisc.edu

Abstract

BACKGROUND:

Adolescents who attend 12-step groups following alcohol and other drug (AOD) treatment are more likely to remain abstinent and to avoid relapse post-treatment. We examined whether 12-step attendance is also associated with a corresponding reduction in health care use and costs.

METHODS:

We used difference-in-difference analysis to compare changes in seven-year follow-up health care use and costs by changes in 12-step participation. Four Kaiser Permanente Northern California AOD treatment programs enrolled 403 adolescents, 13-18-years old, into a longitudinal cohort study upon AOD treatment entry. Participants self-reported 12-step meeting attendance at six-month, one-year, three-year, and five-year follow-up. Outcomes included counts of hospital inpatient days, emergency room (ER) visits, primary care visits, psychiatric visits, AOD treatment costs and total medical care costs.

RESULTS:

Each additional 12-step meeting attended was associated with an incremental medical cost reduction of 4.7% during seven-year follow-up. The medical cost offset was largely due to reductions in hospital inpatient days, psychiatric visits, and AOD treatment costs. We estimate total medical use cost savings at $145 per year (in 2010 U.S. dollars) per additional 12-step meeting attended.

CONCLUSIONS:

The findings suggest that 12-step participation conveys medical cost offsets for youth who undergo AOD treatment. Reduced costs may be related to improved AOD outcomes due to 12-step participation, improved general health due to changes in social network following 12-step participation, or better compliance to both AOD treatment and 12-step meetings.

PMID:
22633367
PMCID:
PMC3430743
DOI:
10.1016/j.drugalcdep.2012.05.002
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center